Eisai offers the Eisai Patient Support Program for patients prescribed LENVIMA or HALAVEN. The Eisai Patient Support Program offers access and reimbursement support.
For more information, search LENVIMA or HALAVEN in this Guide, go online, or call 1.866.613.4724, Monday through Friday, 8:00 AM to 8:00 PM EST.
Oncology-related products: Lenvima® (lenvatinib) capsules, Halaven® (eribulin mesylate) injection
Eisai Patient Support Program offers access and reimbursement support, including:
Eisai offers the Eisai Patient Support Program for patients prescribed LENVIMA or HALAVEN. The Eisai Patient Support Program offers access and reimbursement support.
For more information, search LENVIMA or HALAVEN in this Guide, go online, or call 1.866.613.4724, Monday through Friday, 8:00 AM to 8:00 PM EST.
Oncology-related products: Lenvima® (lenvatinib) capsules, Halaven® (eribulin mesylate) injection
Eisai Patient Support Program offers access and reimbursement support, including:
For more information on the Eisai Patient Support Program, and to review the terms and conditions, visit Eisai Reimbursement Resources (eisaipatientsupport.com) or you can call 1.866.613.4724.
Eligible, commercially insured patients prescribed Lenvima could pay as little as $0 out of pocket for each prescription. Eisai will pay up to $10,000 per year to assist with the out-of-pocket costs for Lenvima. Depending on the insurance plan, a patient could have additional financial responsibility for any amounts over Eisai's maximum liability.
Eligibility criteria:
For questions about the program, call 1.855.347.2448.
There may be times that a healthcare provider needs to dose reduce a patient during the course of Lenvima treatment due to adverse reaction before the patient has finished their current supply. Through the Lenvima Dose Exchange Program, eligible patients that require a dose reduction can exchange up to 15 unused doses for the same number of doses at the reduced dose strength at no additional cost.
The program allows patients to exchange unused 20-mg doses for 14-mg doses and 10-mg doses to 8mg doses when a healthcare provider has directed a dose reduction based on the prescribing information.
Complete the Lenvima dose exchange enrollment form and fax it—along with a prescription—to Sonexus at 1.855.246.5192.
The Lenvima Patient Assistance Program is for patients who need help paying for Lenvima. This program provides Lenvima at no cost to uninsured and financially burdened patients who meet the program eligibility criteria.
To enroll, fax the completed enrollment form to 1.855.246.5192 or call 1.866.613.4274, Monday through Friday, 8:00 AM to 8:00 PM EST. Healthcare professionals can also enroll patients by sending an electronic prescription for Lenvima directly to Sonexus Health Pharmacy Services, which will facilitate the enrollment process into the Eisai Assistance Program.
Note: A patient's signature is required to complete enrollment. Patients can sign the form electronically online.
Eligible, commercially insured patients could pay as little as $0 out of pocket for each prescription. Eisai will pay up to $18,000 per year to assist with the out-of-pocket costs for Halaven. Depending on the insurance plan, a patient could have additional financial responsibility for any amounts over Eisai’s maximum liability.
Eligibility criteria:
To enroll, fax the completed program-specific enrollment form to 1.844.745.2350.
For questions about the program, call 1.855.347.2448.
The Eisai Assistance Program provides Halaven at no cost to patients in need who meet program eligibility criteria.
To determine if patients are eligible, fax the completed enrollment form to 1.855.246.5192 or call 1.866.613.4724, Monday through Friday, 8:00 AM to 5:00 PM EST.
Oncology-related products: Halaven® (eribulin mesylate) injection, Lenvima® (lenvatinib) capsules
The Eisai Assistance Program offers access and reimbursement support, including:
For more information on the Eisai Assistance Program, and to review the terms and conditions, visit Eisai Reimbursement Resources or you can call 1.866.613.4724.
Eligible, commercially insured patients could pay as little as $0 out of pocket for each prescription. Eisai will pay up to $18,000 per year to assist with the out-of-pocket costs for Halaven. Depending on the insurance plan, a patient could have additional financial responsibility for any amounts over Eisai’s maximum liability.
Eligibility criteria:
To enroll, fax the completed program-specific enrollment form to 1.844.745.2350.
For questions about the program, call 1.855.347.2448.
The Eisai Assistance Program provides Halaven at no cost to patients in need who meet program eligibility criteria.
To determine if patients are eligible, fax the completed enrollment form to 1.855.246.5192 or call 1.866.613.4724, Monday through Friday, 8:00 AM to 5:00 PM EST.
Eligible, commercially insured patients prescribed Lenvima could pay as little as $0 out of pocket for each prescription. Eisai will pay up to $40,000 per year to assist with the out-of-pocket costs for Lenvima. Depending on the insurance plan, a patient could have additional financial responsibility for any amounts over Eisai's maximum liability.
Eligibility criteria:
In-office dispensers and integrated delivery networks can enroll commercially insured patients online.
For questions about the program, call 1.855.347.2448.
There may be times that a healthcare provider needs to dose reduce a patient during the course of Lenvima treatment due to adverse reaction before the patient has finished their current supply. Through the Lenvima Dose Exchange Program, eligible patients that require a dose reduction can exchange up to 15 unused doses for the same number of doses at the reduced dose strength at no additional cost.
The program allows patients to exchange unused 20-mg doses for 14-mg doses when a healthcare provider has directed a dose reduction based on the prescribing information.
Complete the Lenvima dose exchange enrollment form and fax it—along with a prescription—to Sonexus at 1.855.246.5192.
The Lenvima Patient Assistance Program is for patients who need help paying for Lenvima. This program provides Lenvima at no cost to uninsured and financially burdened patients who meet the program eligibility criteria.
To enroll, fax the completed enrollment form to 1.855.246.5192 or call 1.866.613.4274, Monday through Friday, 8:00 AM to 8:00 PM EST. Healthcare professionals can also enroll patients by sending an electronic prescription for Lenvima directly to Sonexus Health Pharmacy Services, which will facilitate the enrollment process into the Eisai Assistance Program.
Note: A patient's signature is required to complete enrollment. Patients can sign the form electronically online.